MediciNova announces publication of positive findings on MN-166 (ibudilast)
MediciNova announced the medical journal Neuropsychopharmacology has published a new article on MN-166. The journal reports that MN-166 (ibudilast) was associated with mood improvements on stress- and alcohol-cue exposures, as well as reductions in overall craving, depression and anxiety. January 23, 2017